4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-20-021857
Chief Financial Officer bought 67,306 shares at $0.52 ($34,999)
From the SEC's structured data for this filing
Trades in this filing
Hunt Jonathan Robert · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-22 | Purchase : show line 1 in the form | +67,306 | $0.52 | $34,999 | 67,306 | D |
| Open-market purchases · 67,306 sh · avg $0.52 · $34,999 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-22 | Purchase : show line 2 in the form Warrant (right to buy) | +33,653 | 483,653 | D |
Loading xslF345X03/rdgdoc.xml…